| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.2M | +20.7% | +104.7% |
| Cost of Revenue | $1.9M | -10.5% | +47.2% |
| Gross Profit | $300K | +200.7% | +239.5% |
| R&D Expense | $2.4M | -0.9% | -19.2% |
| SG&A Expense | $4.5M | -9.1% | -42.2% |
| Operating Income | -$6.6M | +13.9% | +39.8% |
| Pre-tax Income | -$7.6M | +7.6% | +42.8% |
| Net Income | -$7.3M | +7.6% | +43.7% |
| EPS (Basic) | -$0.85 | +32.0% | -466.7% |
| EPS (Diluted) | -$0.85 | +32.0% | -466.7% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.6M | -31.5% | +44.4% |
| Short-term Investments | $5.0M | +403.8% | -21.0% |
| Accounts Receivable | $1.2M | +29.0% | +80.1% |
| Inventory | $1.8M | -21.0% | -26.0% |
| Current Assets | $25.6M | +37.5% | +32.2% |
| Total Assets | $36.8M |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$13.2M | — | — |
| Capital Expenditures | $478K | — | — |
| Investing Cash Flow | -$3.2M | — | — |
| Financing Cash Flow | $24.2M | — | — |
| Free Cash Flow | -$13.7M | — | — |
| +7.7% |
| Current Liabilities | $5.0M | +13.8% | -8.1% |
| Total Liabilities | $28.5M | +59.4% | +80.7% |
| Stockholders' Equity | $8.1M | -36.3% | -54.0% |